Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 3Neoplasms 2HIV Infections 2Carcinoma, Hepatocellular 2Acquired Immunodeficiency Syndrome 2Stomach Ulcer 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sarcoma, Kaposi 1Sarcoma 1Muscle Neoplasms 1Hepatitis B 1Duodenal Ulcer 1Adenoviridae Infections 1AIDS-Related Complex 1

Interventions

tetulomab tetraxetan lu-177 2Lutetium 2Isotretinoin 2ziconotide 1interferon gamma-1b 1Zidovudine 1Vinblastine 1Tumor Necrosis Factor-alpha 1Lutetium-177 1Interferon alpha-2 1Inosine Pranobex 1Fluorouracil 1Filgrastim 1Doxorubicin 1Dapsone 1Dacarbazine 1Cidofovir 1Bleomycin 1Acyclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-Related Complex × Tumor Necrosis Factor-alpha × Clear all
NCT00001004 2021-11-04

A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
30 enrolled

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡